Obstetric outcome with low molecular weight heparin therapy during pregnancy.
AffiliationDepartment of Obstetrics and Gynaecology, National Maternity Hospital, Holles St, Dublin 2. email@example.com
Pregnancy Complications, Cardiovascular
MetadataShow full item record
CitationObstetric outcome with low molecular weight heparin therapy during pregnancy. 2012, 105 (1):27-9 Ir Med J
PublisherIrish Medical Journal (IMJ)
JournalIrish medical journal
AbstractThis was a prospective study of women attending a combined haematology/obstetric antenatal clinic in the National Maternity Hospital (2002-2008). Obstetric outcome in mothers treated with low molecular weight heparin (LMWH) was compared to the general obstetric population of 2006. There were 133 pregnancies in 105 women. 85 (63.9%) received prophylactic LMWH and 38 (28.6%) received therapeutic LMWH in pregnancy. 10 (7.5%) received postpartum prophylaxis only. The perinatal mortality rate was 7.6/1000 births. 14 (11.3%) women delivered preterm which is significantly higher than the hospital population rate (5.7%, p<0.05). Despite significantly higher labour induction rates (50% vs 29.2% p<0.01), there was no difference in CS rates compared to the general hospital population (15.4% vs 18.9%, NS). If carefully managed, these high-risk women can achieve similar vaginal delivery rates as the general obstetric population.
- Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
- Authors: Kominiarek MA, Angelopoulos SM, Shapiro NL, Studee L, Nutescu EA, Hibbard JU
- Issue date: 2007 Jun
- Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin.
- Authors: Andersen AS, Berthelsen JG, Bergholt T
- Issue date: 2010
- Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
- Authors: Alguel G, Vormittag R, Simanek R, Kyrle PA, Quehenberger P, Mannhalter C, Husslein P, Pabinger I
- Issue date: 2006 Sep
- A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation.
- Authors: Barbour LA, Oja JL, Schultz LK
- Issue date: 2004 Sep
- The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
- Authors: Voke J, Keidan J, Pavord S, Spencer NH, Hunt BJ, British Society for Haematology Obstetric Haematology Group.
- Issue date: 2007 Nov